PROCEPT BioRoboticsPRCT +1.16%70 Days Inventory is 231.73 as of Mar. 2026, which is 15% above its 10-year median of 202.27. GuruFocus rates PRCT with a GF Score™ of 70/100 and a GF Value™ of $91.98 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 786 Medical Devices & Instruments companies, PROCEPT BioRobotics ranks worse than 63.1% on this metric.
The historical rank and industry rank for PROCEPT BioRobotics's Days Inventory or its related term are showing as below:
PRCT'
s Days Inventory Range Over the Past 10 Years
Min: 191.34 Med: 202.27 Max: 303
Current: 216.65
During the past 7 years, PROCEPT BioRobotics's highest Days Inventory was 303.00. The lowest was 191.34. And the median was 202.27.
PRCT's Days Inventory is ranked worse than 63.1% of 786
companies
in the Medical Devices & Instruments industry
Industry Median: 179.86
vs PRCT: 216.65
PROCEPT BioRobotics's Days Inventory
increased
from Mar. 2025 (216.25) to Mar. 2026 (231.73).
It might indicate that PROCEPT BioRobotics's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
PROCEPT BioRobotics's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.39.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
PROCEPT BioRobotics's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.89.
PROCEPT BioRobotics (NAS:PRCT) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
PROCEPT BioRobotics's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
PROCEPT BioRobotics's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
PROCEPT BioRobotics Days Inventory Related Terms
PROCEPT BioRobotics Days Inventory Historical Data
* Premium members only.
The historical data trend for PROCEPT BioRobotics's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PRCT vs ALMR, AHCO, ENOV: Days Inventory Comparison
For the Medical Devices subindustry, PROCEPT BioRobotics's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PROCEPT BioRobotics Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, PROCEPT BioRobotics's Days Inventory distribution charts can be found below:
* The bar in red indicates where PROCEPT BioRobotics's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PROCEPT BioRobotics (PRCT) has a Days Inventory of 231.73 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on PROCEPT BioRobotics and its competitors. This is 15% above median its historical median of 202.27. Over the past decade, PROCEPT BioRobotics' Days Inventory has ranged from 191.34 to 303.00. According to the industry distribution chart, PROCEPT BioRobotics ranks #496 out of 786 companies in the Medical Devices & Instruments industry, placing it in the top 63.1%.
Is PROCEPT BioRobotics' Days Inventory too high?
PROCEPT BioRobotics' current Days Inventory of 231.73 is 15% above median its 10-year median of 202.27. Over the past 10 years, this metric has ranged from a low of 191.34 to a high of 303.00. The Medical Devices & Instruments industry median Days Inventory is 179.86. PROCEPT BioRobotics' value of 231.73 is 28.8% above this industry median. Based on the distribution chart, PROCEPT BioRobotics ranks #496 out of 786 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, PROCEPT BioRobotics has a GF Score™ of 70/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PROCEPT BioRobotics' Days Inventory compare to ALMR and AHCO?
According to the Medical Devices & Instruments industry distribution chart, PROCEPT BioRobotics ranks #496 out of 786 companies for Days Inventory. This places PROCEPT BioRobotics in the lower half of its industry. The industry median Days Inventory is 179.86. PROCEPT BioRobotics' value of 231.73 is 28.8% above this benchmark. Historically, PROCEPT BioRobotics' own Days Inventory has ranged from 191.34 to 303.00 over the past decade. While the company's 10-year median is 202.27 vs. the industry median of 179.86, PROCEPT BioRobotics has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 179.86, based on 786 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PROCEPT BioRobotics's current Days Inventory of 231.73 is 28.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on PROCEPT BioRobotics and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 179.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PROCEPT BioRobotics's current Days Inventory is 231.73, which is 15% above median its own 10-year median of 202.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PROCEPT BioRobotics stock overvalued right now?
Based on GuruFocus' analysis, PROCEPT BioRobotics (PRCT) is currently considered Significantly Undervalued. The stock's GF Value™ is $91.98, compared to a current price of $20.85 — trading 77.3% below its estimated fair value. The current Days Inventory is 231.73, which is 15% above median its 10-year median of 202.27 and 28.8% above the Medical Devices & Instruments industry median of 179.86. PROCEPT BioRobotics' overall GF Score™ is 70/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For PROCEPT BioRobotics (PRCT), the current Days Inventory is 231.73 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PROCEPT BioRobotics (PRCT) Overvalued in 2026?
Based on GuruFocus' analysis, PROCEPT BioRobotics stock appears to be undervalued.
The current stock price of $20.85 is trading 77.3% below its estimated GF Value™ of $91.98.
GuruFocus considers PROCEPT BioRobotics to be Significantly Undervalued.
Key valuation signals for PRCT:
Days Inventory: 231.73 (15% above median its 10-year median of 202.27)
GF Value™: $91.98 vs. price of $20.85 (77.3% below fair value)
Industry Position: 28.8% above the Medical Devices & Instruments median (#496 of 786)
No single metric tells the full story. See the PRCT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.
70GF Score
Get the complete analysis for PRCT
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PRCT has been successfully added to your 
